Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 12:16:44 +0200Mon, 03 Jun 2024 11:25:00 +0200Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/zilbrysqHuman medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/zilbrysqMon, 03 Jun 2024 11:25:00 +0200Human medicineZilbrysq : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5450-en_1.pdfZilbrysq : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5450-en_1.pdfMon, 03 Jun 2024 11:22:00 +0200Human medicine